|

Allopregnanolone Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Allo

Pipeline

Phase 2: 1

Top Sponsors

  • University of Arizona1

Indications

  • Late Onset Alzheimer Disease1
  • Alzheimer's Disease1
  • Neurodegenerative Diseases1
  • Alzheimer Dementia1

Scottsdale, Arizona1 trial

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Perseverance Research Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.